Results 51 to 60 of about 99,753 (275)
Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
Peripheral T-cell lymphomas (PTCLs) are biologically and clinically heterogeneous diseases almost all of which are associated with poor outcomes. Recent advances in gene expression profiling that helps in diagnosis and prognostication of different ...
Caiqin Xie+3 more
doaj +1 more source
Peripheral T-cell lymphoma: Frequency and distribution in a tertiary referral center in South India
Background and Aim: Peripheral T/NK-cell lymphomas are uncommon types of non-Hodgkin′s lymphoma (NHL) with a higher frequency in Far East countries as compared to the West.
Deepak K Burad+2 more
doaj +1 more source
Targeting TET2 as a Therapeutic Approach for Angioimmunoblastic T Cell Lymphoma. [PDF]
Simple Summary Recent advances in exome sequencing and comprehensive genomic studies have shed new light on the pathogenesis and mutational landscape of Angioimmunoblastic T-cell lymphoma (AITL).
Hu L, Zhang X, Li H, Lin S, Zang S.
europepmc +2 more sources
Identification of cell-type-specific mutations in nodal T-cell lymphomas [PDF]
Recent genetic analysis has identified frequent mutations in ten-eleven translocation 2 (TET2), DNA methyltransferase 3A (DNMT3A), isocitrate dehydrogenase 2 (IDH2) and ras homolog family member A (RHOA) in nodal T-cell lymphomas, including ...
Asabe Y+22 more
core +1 more source
TET2 and DNMT3A mutations are frequently identified in T-cell lymphomas of T follicular helper cell origin (TCL-TFH), clonal hematopoiesis (CH), and myeloid neoplasms (MNs). The relationships among these 3 entities, however, are not well understood.
N. Lewis+16 more
semanticscholar +1 more source
This study deals with 3D laser investigation on the border between the human lymph node T-zone and germinal centre. Only a few T-cells specific for antigen selected B-cells are allowed to enter germinal centres.
Miguel Thomos+4 more
doaj +1 more source
Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience [PDF]
OBJECTIVES: Angioimmunoblastic T-cell lymphoma (AIL) is a rare lymphoma with a poor prognosis and no standard treatment. Here, we report our experiences with 19 patients treated with high-dose chemotherapy and autologous stem cell transplantation (HDC ...
Albo, C. (Carmen)+19 more
core +1 more source
Regulatory T-Cell Depletion in Angioimmunoblastic T-Cell Lymphoma [PDF]
Angioimmunoblastic T-cell lymphoma (AITL) is the most frequent nodal T-cell lymphoma and is characterized by a polymorphic lymph node infiltrate, various dysimmune disorders, and a poor prognosis. Regulatory T-cells (Treg) play an emerging role in the prognosis of non-Hodgkin B-cell lymphoma and mediate significant autoreactive T-cell suppression.
Olivier Hermine+14 more
openaire +3 more sources
Simple Summary Angioimmunoblastic T cell lymphoma (AITL) is probably the most common peripheral T-cell lymphoma. This pathology, although rare, is more common in Europe than in other regions. This lymphoma has a poor prognosis.
Nader Bayda+7 more
semanticscholar +1 more source
Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma
Angioimmunoblastic T cell lymphoma (AITL) is a common subtype of mature peripheral T cell lymphoma (PTCL). As per the 2016 World Health Organization classification, AITL is now considered as a subtype of nodal T cell lymphoma with follicular helper T ...
M. M. Mohammed Saleh+5 more
semanticscholar +1 more source